首页> 美国卫生研究院文献>BJA: British Journal of Anaesthesia >Alternative technique or mitigating strategy for sevoflurane-inducedneurodegeneration: a randomized controlled dose-escalation study of dexmedetomidine inneonatal rats
【2h】

Alternative technique or mitigating strategy for sevoflurane-inducedneurodegeneration: a randomized controlled dose-escalation study of dexmedetomidine inneonatal rats

机译:七氟醚诱导的替代技术或缓解策略神经变性:右美托咪定在大鼠中的随机对照剂量递增研究新生鼠

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

>Background. Brain injury in newborn animals from prolonged anaesthetic exposure has raised concerns for millions of children undergoing anaesthesia every yr. Alternative anaesthetic techniques or mitigating strategies are urgently needed to ameliorate potentially harmful effects. We tested dexmedetomidine, both as a single agent alternative technique and as a mitigating adjuvant for sevoflurane anaesthesia. >Methods. Neonatal rats were randomized to three injections of dexmedetomidine (5, 25, 50, or 100 µg kg−1 every 2 h), or 6 h of 2.5% sevoflurane as a single agent without or with dexmedetomidine (1, 5, 10, or 20 µg kg−1 every 2 h). Heart rate, oxygen saturation, level of consciousness, and response to pain were assessed. Cell death was quantified in several brain regions. >Results. Dexmedetomidine provided lower levels of sedation and pain control than sevoflurane. Exposure to either sevoflurane or dexmedetomidine alone did not cause mortality, but the combination of 2.5% sevoflurane and dexmedetomidine in doses exceeding 1 µg kg−1 did. Sevoflurane increased apoptosis in all brain regions; supplementation with dexmedetomidine exacerbated neuronal injury, potentially as a result of ventilatory or haemodynamic compromise. Dexmedetomidine by itself increased apoptosisonly in CA2/3 and the ventral posterior nucleus, but not in prefrontal cortex,retrosplenial cortex, somatosensory cortex, subiculum, lateral dorsal thalamic nucleaus,or hippocampal CA1.>Conclusions. We confirm previous findings of sevoflurane-induced neuronalinjury. Dexmedetomidine, even in the highest dose, did not cause similar injury, butprovided lesser degrees of anaesthesia and pain control. No mitigation ofsevoflurane-induced injury was observed with dexmedetomidine supplementation, suggestingthat future studies should focus on anaesthetic-sparing effects of dexmedetomidine, ratherthan injury-preventing effects.
机译:>背景。长期麻醉暴露对新生动物的脑损伤引起每年数以百万计接受麻醉的儿童的关注。迫切需要替代麻醉技术或缓解策略,以减轻潜在的有害影响。我们测试了右美托咪定,它既是单药替代技术,又是七氟醚麻醉的缓解佐剂。 >方法。将新生大鼠随机分为三剂右美托咪定注射液(每2h分别注射5、25、50或100 µg kg -1 )或6h的2.5%七氟醚不使用或不使用右美托咪定的单一药物(每2小时1、5、10或20 µg kg -1 )。评估心率,血氧饱和度,意识水平和对疼痛的反应。在几个脑区域中量化了细胞死亡。 >结果。与七氟醚相比,右美托咪定的镇静和镇痛效果更低。单独接触七氟醚或右美托咪定都不会导致死亡,但是2.5%的七氟醚和右美托咪定的组合使用剂量超过1 µg kg -1 时,却没有引起死亡。七氟醚可增加所有脑区域的凋亡。右美托咪定的补充可能会加剧通气或血流动力学损害,从而加剧神经元损伤。右美托咪定本身会增加细胞凋亡仅在CA2 / 3和腹后核中,而不在前额叶皮层中,脾后皮质,体感皮质,下丘脑,丘脑外侧背核,或海马CA1。>结论。我们证实了七氟醚诱导的神经元的先前发现受伤。右美托咪定即使最大剂量也不会引起类似的伤害,但是提供了较少的麻醉和疼痛控制程度。不缓解补充右美托咪定可观察到七氟醚引起的损伤,提示未来的研究应侧重于右美托咪定的麻醉剂保存作用,比预防伤害的效果要好。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号